A mostrar 1 - 4 resultados de 4 para a pesquisa 'Colin A Flaveny', tempo de pesquisa: 0.03seg Refinar resultados
  1. 1
    Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice.

    Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice. Por Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny

    Publicado em 2020-01-01
    Obter o texto integral
    Artigo
  2. 2
    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis Por Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander-Tetri, Thomas P. Burris

    Publicado em 2015-04-01
    Obter o texto integral
    Artigo
  3. 3
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.

    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. Por Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Kristine Griffett, Thomas P Burris, Colin A Flaveny

    Publicado em 2021-01-01
    Obter o texto integral
    Artigo
  4. 4
    Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.

    Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis. Por Bin Li, Colin A Flaveny, Camilla Giambelli, Dennis Liang Fei, Lu Han, Brian I Hang, Feng Bai, Xin-Hai Pei, Vania Nose, Oname Burlingame, Anthony J Capobianco, Darren Orton, Ethan Lee, David J Robbins

    Publicado em 2014-01-01
    Obter o texto integral
    Artigo

Ferramentas de pesquisa: